$4.15
0.020.48%
Ult. Agg.: Nov 6, 5:49 PM
Artiva Biotherapeutics (ARTV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.63 | $-0.64 | 1.56 % |
| Q1 | May 8, 2026 | $-0.95 | $-0.85 | -11.8 % |
| Q4 | Mar 10, 2026 | $-0.84 | $-0.83 | -1.20 % |
| Q3 | Nov 12, 2025 | $-0.88 | $-0.85 | -3.53 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2024 | $0 | $70.00K | -100.0 % |
| Q2 | Aug 29, 2024 | $0 | $70.00K | -100.0 % |
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.64 | $-0.85 | $-0.83 | $-0.85 |
| Actual | $-0.63 | $-0.95 | $-0.84 | $-0.88 |
| Surprise | +1.56% | -11.8% | -1.20% | -3.53% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.54 | $-0.66 | $-0.67 | $-0.63 |
| Revenue | ||||
| Consensus | — | — | — | — |